Austin Angelo

About the Author Austin Angelo


Canaccord Genuity Remains a Buy on Brookfld Asset A LV

Today, an analyst has provided a rating update for the Financial sector company, Brookfld Asset A LV (TSX: BAM.A).

Oppenheimer Maintains Their Buy Rating on Syros Pharmaceuticals

Oppenheimer analyst Leah R. Cann maintained a Buy rating on Syros Pharmaceuticals (NASDAQ: SYRS) today and set a price target of $28.

Canaccord Genuity Sticks to Their Buy Rating for WPT Industrl REIT US

In a new note to investors today, an analyst has provided a rating update for the Financial sector company, WPT Industrl REIT US …

Rosenblatt Securities Believes Rapid7 (NASDAQ: RPD) Won’t Stop Here

In a report released yesterday, Marshall Senk from Rosenblatt Securities maintained a Buy rating on Rapid7 (NASDAQ: RPD), with a price target of …

Barrington Thinks Fluent Inc’s Stock is Going to Recover

In a report released yesterday, James Goss from Barrington maintained a Buy rating on Fluent Inc (NASDAQ: FLNT), with a price target of …

Cantor Fitzgerald Believes Worldpay Inc (NYSE: WP) Still Has Room to Grow

In a report released today, Joseph Foresi from Cantor Fitzgerald maintained a Buy rating on Worldpay Inc (NYSE: WP), with a price target …

Blucora Gets a Buy Rating from Benchmark Co.

In a report released today, Daniel Kurnos from Benchmark Co. maintained a Buy rating on Blucora (NASDAQ: BCOR), with a price target of …

H.C. Wainwright Keeps a Hold Rating on Valeant Pharma

In a report released today, Ram Selvaraju from H.C.

Arista Networks Initiated with a Buy at Credit Suisse

In a report released yesterday, Sami Badri from Credit Suisse initiated coverage with a Buy rating on Arista Networks (NYSE: ANET) and a …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts